EUVIMEDEUVIMED entdecken
Crossref

Carbapenemase-encoding genes among enterobacterales isolated from blood culture in oncology care

Parthiban Balakrishnan, Subhranshu Mandal, Sankar Sengupta

Journal of Laboratory Physicians · 14.08.2026 · 18 · 389-393

DOI: 10.25259/jlp_321_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Laboratory Physicians, online erschienen am 14.08.2026. Verfasst von Parthiban Balakrishnan und 2 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Carbapenemase-producing carbapenem-resistant enterobacterales (CP-CRE) pose a significant clinical challenge, especially in oncological patients, representing a substantial therapeutic hazard. The study aims to assess the prevalence and profile of carbapenemase genes among CP-CRE isolates from bloodstream infections (BSIs) in a tertiary care cancer institute in Eastern India. Materials and Methods: An 18-month prospective, observational, single-center study was conducted. Blood culture isolates from suspected BSIs were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Antimicrobial susceptibility testing was performed using automated broth microdilution (VITEK-2). Carbapenemase gene detection was carried out using the RESIST-5 O.K.N.V.I. lateral flow immunoassay targeting New Delhi metallo-β-lactamase (NDM), oxacillinase-48-like carbapenemase (OXA-48), Klebsiella pneumoniae carbapenemase (KPC), Verona integron-encoded metallo-β-lactamase (VIM), and imipenemase (metallo-β-lactamase) (IMP). Statistical analysis: Descriptive statistics summarized prevalence and distribution patterns.

Results

Of 1674 blood cultures processed, 532 (31.7%) were positive. Enterobacterales were isolated in 259 cases (48.7% of positive cultures). Among these, 94 isolates (36.3% of Enterobacterales; 17.6% of culture-positive samples) were carbapenem-resistant. K. pneumoniae (56.4%) and Escherichia coli (36.2%) were the predominant species. Gene profiling revealed NDM alone (44.6%) as the most common, followed by NDM + OXA-48 (31.9%) and OXA-48 alone (17%). No isolates carried KPC, VIM , or IMP genes. 6 (6.3% of the carbapenem-resistant enterobacterial isolates) showed no detectable genes by the RESIST-5 panel. Mortality was 28.7% ( n = 94). For most CP-CRE, colistin and tigecycline remained the principal in vitro therapeutic options following further clinical and laboratory evaluations.

Conclusions

The predominance of NDM and OXA-48 genes in bloodstream isolates highlights the critical need for stewardship practices involving resistance gene profiling. Routine carbapenemase gene profiling using simple immunochromatographic tests may facilitate earlier clinical decision-making in similar clinical settings, particularly in oncology settings, while interpretation should be integrated with antimicrobial susceptibility testing and clinical context.

Zitieren

APA

Balakrishnan, P., Mandal, S., & Sengupta, S. (2026). Carbapenemase-encoding genes among enterobacterales isolated from blood culture in oncology care. Journal of Laboratory Physicians, 18, 389-393. https://doi.org/10.25259/jlp_321_2025

Vancouver

Balakrishnan P, Mandal S, Sengupta S. Carbapenemase-encoding genes among enterobacterales isolated from blood culture in oncology care. Journal of Laboratory Physicians. 2026;18:389-393. doi:10.25259/jlp_321_2025

BibTeX
@article{Balakrishnan2026,
  author = {Balakrishnan, Parthiban and Mandal, Subhranshu and Sengupta, Sankar},
  title = {Carbapenemase-encoding genes among enterobacterales isolated from blood culture in oncology care},
  journal = {Journal of Laboratory Physicians},
  year = {2026},
  volume = {18},
  pages = {389--393},
  doi = {10.25259/jlp_321_2025}
}
Kostenlos starten →